Øyvind Molberg Selected Research

Celiac Disease (Celiac Sprue)

10/2021	Small intestinal biopsy findings consistent with celiac disease in patients with idiopathic inflammatory myopathy: Review of existing literature.
1/2019	Distinct phenotype of CD4+ T cells driving celiac disease identified in multiple autoimmune conditions.
8/2006	A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells.
9/2005	Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.
10/2004	The molecular basis for oat intolerance in patients with celiac disease.
8/2004	Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion.
8/2003	Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease.
9/2002	Structural basis for gluten intolerance in celiac sprue.
9/2002	Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process.
9/2002	Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Øyvind Molberg Research Topics

Disease

15	Systemic Scleroderma (Systemic Sclerosis) 01/2023 - 08/2015
10	Fibrosis (Cirrhosis) 01/2022 - 10/2005
10	Celiac Disease (Celiac Sprue) 10/2021 - 09/2002
9	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 08/2009
6	Inflammation (Inflammations) 01/2022 - 08/2003
6	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019 - 08/2009
6	Mixed Connective Tissue Disease (MCTD) 12/2017 - 07/2013
5	Rheumatoid Arthritis 01/2023 - 04/2006
5	Pulmonary Arterial Hypertension 01/2022 - 08/2015
5	Pulmonary Hypertension 10/2020 - 01/2016
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2023 - 01/2019
3	Dermatomyositis (Dermatopolymyositis) 01/2023 - 08/2009
3	Inclusion Body Myositis 10/2021 - 11/2012
2	Genetic Risk Score 10/2023 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 09/2002
2	Disease Progression 01/2019 - 01/2017
2	Pneumonia (Pneumonitis) 10/2018 - 08/2016
2	Arthritis (Polyarthritis) 01/2018 - 01/2016
2	Neoplasms (Cancer) 01/2017 - 08/2009
2	Immune System Diseases (Immune Disorders) 01/2016 - 09/2005
1	Nephritis 10/2023
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2023
1	Hypersensitivity (Allergy) 01/2023
1	Lipodystrophy 01/2023
1	Left Ventricular Dysfunction 01/2022
1	Rhinosinusitis 01/2020
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2020
1	Osteitis 01/2020
1	Systemic Vasculitis 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Vascular Remodeling 11/2017
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2017
1	Giant Cell Arteritis (Horton Disease) 01/2017
1	Sclerosing Cholangitis 01/2017
1	Liver Diseases (Liver Disease) 01/2017
1	Skin Diseases (Skin Disease) 01/2017
1	Ulcerative Colitis 01/2017
1	Spontaneous Abortion (Miscarriage) 01/2017
1	Polymyositis 01/2017
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2017
1	Pericarditis 01/2016
1	Pleurisy (Pleuritis) 01/2016

Drug/Important Bio-Agent (IBA)

10	AntibodiesIBA 01/2018 - 08/2009
9	AutoantibodiesIBA 01/2022 - 09/2002
7	Glutens (Glutelin)IBA 01/2019 - 09/2002
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
6	Peptides (Polypeptides)IBA 01/2017 - 09/2002
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2003
3	AntigensIBA 01/2019 - 04/2006
3	Ligases (Synthetase)IBA 01/2017 - 08/2009
3	Protein Glutamine gamma Glutamyltransferase 2IBA 08/2003 - 09/2002
2	Tumor Necrosis Factor InhibitorsIBA 01/2023 - 01/2017
2	ChemokinesIBA 01/2022 - 10/2018
2	InterferonsIBA 01/2022 - 01/2021
2	EndostatinsIBA 01/2022 - 08/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2019 - 01/2016
2	Carbon MonoxideIBA 01/2019 - 05/2015
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2017 - 01/2017
2	Amino Acids FDA Link 01/2017 - 04/2015
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2006 - 09/2002
1	anti-dsDNA autoantibodyIBA 10/2023
1	AdipokinesIBA 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 01/2023
1	AdiponectinIBA 01/2023
1	Deoxyribonuclease I (Nickase)IBA 01/2023
1	Antirheumatic Agents (DMARD)IBA 01/2023
1	LigandsIBA 01/2022
1	Complement C4 (Complement Component 4)IBA 01/2022
1	LipidsIBA 01/2022
1	Chemokine CCL21IBA 01/2022
1	CytokinesIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	OsteopontinIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Angiopoietin-2IBA 01/2022
1	Interleukin-13IBA 01/2021
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	HLA-DQ Antigens (HLA-DQ)IBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2018
1	anti-scl-70 autoantibodiesIBA 01/2018
1	Biocompatible Materials (Biomaterials)IBA 01/2018
1	arginine deiminaseIBA 01/2018
1	EpitopesIBA 01/2018
1	Protein-Arginine Deiminase Type 4IBA 01/2018
1	Platelet-Derived Growth FactorIBA 11/2017
1	Proto-Oncogene Proteins c-fos (FRAs)IBA 11/2017
1	Matrix Metalloproteinase 10 (Stromelysin 2)IBA 11/2017
1	PlasminogenIBA 01/2017
1	RNA Polymerase IIIIBA 01/2017
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2017
1	Chemokine CCL18IBA 08/2016

Therapy/Procedure

4	Therapeutics 10/2021 - 09/2002
2	Transplantation 01/2023 - 01/2021
2	Gluten-Free Diet 10/2021 - 10/2004
2	Fecal Microbiota Transplantation 01/2020 - 01/2020
1	Nasal Surgical Procedures 01/2020
1	Operative Surgical Procedures 01/2020
1	Induced Abortion (Induced Abortions) 01/2017